Abeona Therapeutics Inc
NASDAQ:ABEO

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
NASDAQ:ABEO
Watchlist
Price: 4.92 USD 1.65% Market Closed
Market Cap: 240.1m USD

Intrinsic Value

ABEO doesn't have a meaningful market cap.

The intrinsic value of one ABEO stock under the Base Case scenario is 12.23 USD. Compared to the current market price of 4.92 USD, Abeona Therapeutics Inc is Undervalued by 60%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABEO Intrinsic Value
12.23 USD
Undervaluation 60%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Abeona Therapeutics Inc

ABEO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ABEO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Abeona Therapeutics Inc
NASDAQ:ABEO
US
Biotechnology
Market Cap
224.6m USD
IPO
Sep 19, 1980
US
Biotechnology
Market Cap
224.6m USD
IPO
Sep 19, 1980
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABEO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Abeona Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Abeona Therapeutics Inc

Current Assets 100.9m
Cash & Short-Term Investments 97.7m
Receivables 1.7m
Other Current Assets 1.5m
Non-Current Assets 8.1m
PP&E 8m
Other Non-Current Assets 96k
Efficiency

Free Cash Flow Analysis
Abeona Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Abeona Therapeutics Inc

Revenue
0 USD
Operating Expenses
-64.2m USD
Operating Income
-64.2m USD
Other Expenses
477k USD
Net Income
-63.7m USD
Fundamental Scores

ABEO Profitability Score
Profitability Due Diligence

Abeona Therapeutics Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

Abeona Therapeutics Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

ABEO Solvency Score
Solvency Due Diligence

Abeona Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
60/100
Solvency
Score

Abeona Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABEO Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast ABEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABEO is 17.09 USD with a low forecast of 9.6 USD and a high forecast of 26.25 USD.

Lowest
Price Target
9.6 USD
95% Upside
Average
Price Target
17.09 USD
247% Upside
Highest
Price Target
26.25 USD
434% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ABEO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ABEO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ABEO stock?

The intrinsic value of one ABEO stock under the Base Case scenario is 12.23 USD.

Is ABEO stock undervalued or overvalued?

Compared to the current market price of 4.92 USD, Abeona Therapeutics Inc is Undervalued by 60%.

Back to Top